The Oxford-Astrazeneca vaccine, marketed in India as Covishield was one of the first competitors in the race and largely considered a safe vaccine to use. However, recent reports from

France, regarding certain side-effects made many consider it a tad bit unsafe for use, especially amongst the senior groups. Nonetheless, the factsheet maintains that a person can develop

some symptoms, on the milder side such as pain, warmth, itching, bruising, fatigue, chills, fever, nausea, muscle ache, lumps and malaise. Severe side-effects such as extremely high

temperature (over 102 degrees Farhenheit), coughing, breathing difficulties, nervous problems, anaphylaxis are possible, though rare. It should be noted that the severe reactions, observed